Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16368055 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of MK0663 in Patients With Chronic Low Back Pain (0663-806)(COMPLETED)
Condition: Chronic Low Back Pain
Interventions: Drug: MK0663, etoricoxib / Duration of Treatment: 4 weeks;   Drug: Comparator: diclofenac / Duration of Treatment: 4 weeks

Indicates status has not been verified in more than two years